Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation model

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 780-789

  Zhang, Yinzhong ^a   Lin, Xinchun ^a   Koga, Kiyokazu ^a   Takahashi, Koichiro ^a   Linge, Helena M ^a   Mello, Adriana ^a   Laragione, Teresina ^a   Gulko, Percio S ^a   Miller, Edmund J ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KERATINOCYTE DERIVED CHEMOKINE; LACTATE DEHYDROGENASE; LIPOTEICHOIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELOPEROXIDASE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENETIC SUSCEPTIBILITY; IN VITRO STUDY; KERATINOCYTE; LOBAR PNEUMONIA; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; QUANTITATIVE TRAIT LOCUS; RAT; STRAIN DIFFERENCE;

ANIMALS; ANIMALS, CONGENIC; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL2; CHEMOKINES; FEMALE; IMIDAZOLES; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHIL INFILTRATION; NEUTROPHILS; PEPTIDOGLYCAN; PHOSPHORYLATION; PNEUMONIA; PYRIDINES; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED F344; SPECIES SPECIFICITY; TEICHOIC ACIDS;

EID: 79960703285     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00064     Document Type: Article

References (56)

1. Mizgerd JP. (2006) Lung infection-a public health priority. PLoS Med. 3:e76.
2. O'Brien JM, Jr., Ali NA, Aberegg SK, Abraham E. (2007) Sepsis. Am. J. Med. 120:1012-22.
3. Taira BR, et al. (2009) Ventilator-associated pneumonia in pediatric trauma patients. Pediatr. Crit. Care Med. 10:491-4.
4. Sokka T, Abelson B, Pincus T. (2008) Mortality in rheumatoid arthritis: 2008 update. Clin. Exp. Rheumatol. 26:S35-61.
5. Barnes KC. (2005) Genetic determinants and ethnic disparities in sepsis-associated acute lung injury. Proc. Am. Thorac. Soc. 2:195-201.
6. Garcia JG, Moreno Vinasco L. (2006) Genomic insights into acute inflammatory lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1113-7.
7. Raz E. (2007) Organ-specific regulation of innate immunity. Nat. Immunol. 8:3-4.
8. Richards MJ, Edwards JR, Culver DH, Gaynes RP. (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21:510-5.
9. Styers D, Sheehan DJ, Hogan P, Sahm DF. (2006) Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5:2.
10. Vincent JL, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34:344-53.
11. Ventura CL, et al. (2008) Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia. Infect. Immun. 76:5862-72.
12. Wang JE, et al. (2004) Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit. Care Med. 32:546-52.
13. Overland G, et al. (2003) Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro. Surg. Infect. (Larchmt). 4:181-91.
14. Hoogerwerf JJ, et al. (2008) Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 178:34-41.
15. Hattar K, et al. (2006) Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation. Crit. Care Med. 34:835-41.
16. Leemans JC, Heikens M, van Kessel KP, Florquin S, van der Poll T. (2003) Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice. Clin. Diagn. Lab. Immunol. 10:950-3.
17. Lin X, et al. (2007) Age-dependent changes and the increased injurious potential of macrophage migration inhibitory factor in sepsis. Am. J. Resp. Crit. Care Med. 175:A696.
18. Remmers EF, et al. (2002) Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum. 46:2225-34.
19. Laragione T, et al. (2007) The arthritis severity quantitative trait loci Cia4 and Cia6 regulate neutrophil migration into inflammatory sites and levels of TNF-alpha and nitric oxide. J. Immunol. 178:2344-51.
20. Brenner M, et al. (2005) The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane- induced arthritis. J. Immunol. 174:7894-903.
21. Lee WL, Downey GP. (2001) Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 7:1-7.
22. Kindt GC, Gadek JE, Weiland JE. (1991) Initial recruitment of neutrophils to alveolar structures in acute lung injury. J. Appl. Physiol. 70:1575-85.
23. Pay S, et al. (2006) Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR-2 contribute to the chronic inflammation or erosive changes? Joint Bone Spine. 73:691-6.
24. Weissmann G. (2004) Pathogenesis of rheumatoid arthritis. J. Clin. Rheumatol. 10:S26-31.
25. Miller EJ, Brelsford WG. (1993) Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout. J. Rheumatol. 20:1250-2.
26. Kurdowska A, et al. (1996) Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J. Immunol. 157:2699-706.
27. Yang H, Wang H, Czura CJ, Tracey KJ. (2005) The cytokine activity of HMGB1. J. Leukoc. Biol. 78:1-8.
28. Morand EF, Leech M. (2005) Macrophage migration inhibitory factor in rheumatoid arthritis. Front. Biosci. 10:12-22.
29. Matsuda N, Nishihira J, Takahashi Y, Kemmotsu O, Hattori Y. (2006) Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. Am. J. Respir. Cell Mol. Biol. 35:198-205.
30. Takahashi K, et al. (2009) Macrophage CD74 contributes to MIF-induced pulmonary inflammation PMC2681459. Respir. Res. 10:33.
31. Linge HM, et al. (2009) Role of Macrophage Migration Inhibitory Factor in a Murine Model of Lung Inflammation. Am. J. Respir. Crit. Care Med. 179:A5651.
32. Thobe BM, et al. (2007) The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following traumahemorrhage. J. Cell. Physiol. 210:667-75.
33. Re F, Strominger JL. (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692-9.
34. Janardhan KS, Sandhu SK, Singh B. (2006) Neutrophil depletion inhibits early and late monocyte/ macrophage increase in lung inflammation. Front Biosci. 11:1569-76.
35. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. (1993) Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax. 48:765-9.
36. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. (1995) The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U. S. A. 92:10359-63.
37. Lien E, Ingalls RR. (2002) Toll-like receptors. Crit. Care Med. 30: S1-S11.
38. Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK. (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G829-38.
39. Bhattacharyya S, Dudeja PK, Tobacman JK. (2008) Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim. Biophys. Acta. 1780:973-82.
40. Yoo S, Han S, Park YS, Lee JH, Oh U, Hwang SW. (2009) Lipoxygenase inhibitors suppressed carrageenan- induced Fos-expression and inflammatory pain responses in the rat. Mol. Cells. 27:417-22.
41. Zweifel BS, et al. (2008) A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors. Eur. J. Pharmacol. 584:166-74.
42. Bhattacharyya S, et al. (2008) Toll-like receptor 4 mediates induction of the Bcl10-NFkappaBinterleukin- 8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol. Chem. 283:10550-8.
43. Zhu YN, et al. (2006) Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-c is associated with the activation of extracellular signal-related kinase. Int. Immunol. 18:981-90.
44. Farley KS, et al. (2006) Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 290: L1164-72.
45. Maus U, et al. (2002) The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am. J. Respir. Crit. Care Med. 166:268-73.
46. Lomas-Neira J, et al. (2006) Role of alveolar macrophage and migrating neutrophils in hemorrhage- induced priming for ALI subsequent to septic challenge. Am. J. Physiol. Lung Cell Mol. Physiol. 290: L51-8.
47. Frank JA, Wray CM, McAuley DF, Schwendener R, Matthay MA. (2006) Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator- induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1191-8.
48. Nader ND, McQuiller PS, Raghavendran K, Knight PR. (2007) The role of alveolar macrophages in the pathogenesis of aspiration pneumonitis. Immunol. Invest. 36:457-71.
49. Reutershan J, Ley K. (2004) Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit. Care. 8:453-61.
50. Puneet P, Moochhala S, Bhatia M. (2005) Chemokines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L3-15.
51. Hirayama S, Shiraishi T, Shirakusa T, Higuchi T, Miller EJ. (2006) Prevention of neutrophil migration ameliorates rat lung allograft rejection. Mol. Med. 12:208-13.
52. Hayashi S, Yatsunami J, Fukuno Y, Kawashima M, Miller EJ. (2002) Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice. Lung. 180:339-48.
53. Lomas-Neira JL, Chung CS, Grutkoski PS, Miller EJ, Ayala A. (2004) CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J. Leukoc. Biol. 76:58-64.
54. Miller EJ, Cohen AB, Peterson BT. (1996) Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflamm. Res. 45:393-7.
55. Lin X, et al. (2005) Alpha-chemokine receptor blockade reduces high mobility group box 1 protein- induced lung inflammation and injury and improves survival in sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L583-90.
56. Miller EJ, Nagao S, Carr FK, Noble JM, Cohen AB. (1996) Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflamm. Res. 45:386-92.